Market Overview:
The global Circulating Cell-Free Tumor DNA Market is estimated to reach a valuation of US$ 6.1 billion by 2023, growing at a CAGR of X% during the forecast period 2023-2030. This market research report by Coherent Market Insights highlights the significant growth potential of the market. Circulating Cell-Free Tumor DNA refers to small DNA fragments that are released into the bloodstream by tumor cells. The market for these DNA fragments is driven by ... Read more

The circulating cell-free tumor DNA market involves products and tools utilized for isolating and analyzing circulating tumor DNA fragments present in blood or other body fluids. Circulating cell-free tumor DNA serves as a non-invasive alternative to tissue biopsies and provides important insights into somatic mutations present in tumors. They aid doctors in monitoring treatment response, detecting recurrence, and better understanding the genetic underpinnings of disease. The demand for ... Read more